Jenny Thirlway

Title: Jenny Thirlway: Innovator in Protein Drug Conjugates

Introduction

Jenny Thirlway is a prominent inventor based in York, GB. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of protein drug conjugates. Her innovative work focuses on enhancing targeted drug delivery applications, which is crucial for improving therapeutic outcomes.

Latest Patents

Jenny Thirlway holds a patent for "Materials and methods relating to linkers for use in protein drug conjugates." This invention relates to protein drug conjugates, methods of manufacturing them, and their therapeutic applications. Specifically, it involves the use of a globular protein, an improved linker, and a drug designed for targeted drug delivery.

Career Highlights

Jenny is currently associated with Iksuda Therapeutics Limited, where she applies her expertise in biochemistry and drug development. Her work at Iksuda Therapeutics focuses on advancing innovative therapies that leverage her patented technologies.

Collaborations

Jenny has collaborated with notable professionals in her field, including Anthony David Baxter and Christopher Michael Birchall. These collaborations have further enriched her research and development efforts in protein drug conjugates.

Conclusion

Jenny Thirlway is a trailblazer in the realm of protein drug conjugates, with her innovative patent paving the way for advancements in targeted therapies. Her contributions are vital for the future of biopharmaceuticals, and her work continues to inspire others in the field.